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ﬁnished not after the peer review process [1], but after its original
publication and the letters sent to the journal by readers and the
wider audience. An example of this is the case of the article by
Azevedo et al. [2] published in Volume 1, Issue 2, of Value in Health
Regional Issues (VIHRI) (focusing on Latin America). After receiving
a Letter to the Editors by Dr. Jose Elias Rizk Aziz regarding this
article, the editorial team reviewed the article and sent the letter,
as well as other comments, to the authors, who promptly
responded with a response Letter to the Editors, as well as with
an erratum of the original article. We think that these letters and
the new version of the article, published in this VIHRI issue,
contribute to the iterative process of improving publication
through the interaction of authors, with the readers and editors.
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